Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Young Investigator Award (lymphatic research | worldwide)

Lymphatic Malformation Institute (LMI)

The Alfie Milne Young Investigator Award is a one-year grant designed to support early career researchers, such as postdoctoral and clinical fellows or instructors, pursuing promising research ideas related to complex lymphatic anomalies including Gorham Stout Disease (GSD), Generalized Lymphatic Anomaly (GLA), Kaposiform Lymphangiomatosis (KLA) and Central Conducting Lymphatic Anomaly (CCLA). This grant aims to cultivate the best and brightest researchers of the future who demonstrate a commitment to a career in lymphatic research. This is a mentored award, and the research project is conducted under the guidance of a scientific mentor. U.S. and international researchers with a focus on complex lymphatic anomalies can apply.

Alfie Milne Young Investigator Award is a one-year grant totaling $25,000 that supports personnel and/or direct research expenses. This award is made possible by a charitable donation from Lymphangiomatosis & Gorham’s Disease Alliance, United Kingdom (LGDA UK).

How to Apply
Submit a LOI to the LMI. If your LOI is selected, you will be invited to submit a full grant application.

Letter of Interest Instructions
The completed one-page LOI is to be emailed to grants@lmiresearch.org and due no later than Friday, May 30, 2025 by 11:59pm (EST).

Full Applications
Invitation only. Full applications due Friday, August 29, 2025 no later than 11:59pm (EST) and emailed to grants@lmiresearch.org.

Documents
See below for the links to download instructions and form templates for the Alfie Milne Young Investigator application.

Grant Review Process

Grants will be reviewed for scientific content and relevance to the goals of the RFA.
Full applications proceed through a two-step review process. The first step includes external review and rating with an assessment of the strengths and weaknesses of each application based on the defined review criteria described below. During the second step, funding recommendations are determined based on an assessment of the reviewer scores and written comments. Final decision of funding will be made by leadership of LMI, LGDA, and LGD Alliance Europe.

Anonymous reviewer feedback is shared with the applicant.

Confidentiality
The LMI Programs are a confidential process and all content of the LOIs and Full Applications will be kept confidential. In order to encourage sharing of new techniques and findings to advance science, after funding decisions are made, the LMI will share a non-confidential lay summary of the research proposals received (required with your letter of intent), including those that were not funded, with LGDA and LGDA Europe (funding organizations). The LMI aims to respect and protect the integrity of your work, and thus will not release any proprietary information.

Specialties

Genetics & Genomics

Others

Eligibility Requirements

This RFA is open globally. International applicants are invited to apply. Graduate and medical students actively doing research are eligible for the award. Additionally, individuals with a PhD, MD, or MD/PhD who do not have an appointment higher than Instructor are eligible to apply.

Sponsor Details

Sponsor Institute/Organizations: Lymphatic Malformation Institute (LMI)

Address: Dr. Michael Dellinger Director of Research mdellinger@lmiresearch.org Tiffany Ferry President tferry@lmiresearch.org

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity